Clinical Trials in Austin

Showing 4181-4200 of 15,205 trials

Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness

NCT02189798

The purpose of this feasibility study is to evaluate whether low-frequency acoustic hearing sensitivity can be preserved in newly implanted adults with partial deafness (considerable low frequency acoustic hearing profiles with severe-to-profound high frequency sensorineural hearing loss) using the HiResolution™ 90K™ Advantage cochlear implant with the HiFocus™ Mid-Scala electrode to support the development of electro-acoustic stimulation technology (EAS).

Hearing LossPartial DeafnessHearing Disorders+2 more

Advanced Bionics67 participantsStarted Oct 2014

Washington D.C., District of Columbia, United States • Tampa, Florida, United States • Lexington, Kentucky, United States +8 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

NCT05799157

This Phase 2 study has been designed to determine the safety and efficacy of repeated treatment sessions of VDMN-21 patch at two dose strengths as compared to a matched vehicle control patch in subjects with verruca vulgaris

Verruca VulgarisWartsCommon Wart

Veradermics, Inc.153 participantsStarted Feb 2023

Fort Smith, Arkansas, United States • San Diego, California, United States • Plainfield, Indiana, United States +13 more locations

Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness

Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

Find Trials by Condition in Austin

Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

PRV-3279-2a Trial in Systemic Lupus

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

Afrezza® INHALE-1 Study in Pediatrics

A Study of PF-07260437 in Advanced or Metastatic Solid Tumors

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout

The OBSERVE Protocol

Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

The EMBER Trial for Weight Management Engagement

Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Efficacy in iNPH Shunting (PENS) Trial

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

T1D Pregnancy & Me